CN101049320B - 一种蜂胶醇提取物口含片 - Google Patents
一种蜂胶醇提取物口含片 Download PDFInfo
- Publication number
- CN101049320B CN101049320B CN200710015492A CN200710015492A CN101049320B CN 101049320 B CN101049320 B CN 101049320B CN 200710015492 A CN200710015492 A CN 200710015492A CN 200710015492 A CN200710015492 A CN 200710015492A CN 101049320 B CN101049320 B CN 101049320B
- Authority
- CN
- China
- Prior art keywords
- propolis
- parts
- extractive
- alcohol extract
- propolis alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000241413 Propolis Species 0.000 title claims abstract description 83
- 229940069949 propolis Drugs 0.000 title claims abstract description 83
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 57
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 24
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 25
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 11
- 229930006000 Sucrose Natural products 0.000 claims description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 11
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 11
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 11
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 11
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- 229910052708 sodium Inorganic materials 0.000 claims description 11
- 235000019698 starch Nutrition 0.000 claims description 11
- 239000008107 starch Substances 0.000 claims description 11
- 239000005720 sucrose Substances 0.000 claims description 11
- 239000000811 xylitol Substances 0.000 claims description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 11
- 229960002675 xylitol Drugs 0.000 claims description 11
- 235000010447 xylitol Nutrition 0.000 claims description 11
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 8
- 229940041616 menthol Drugs 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 235000012041 food component Nutrition 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 229960000935 dehydrated alcohol Drugs 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 229940032147 starch Drugs 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 241001502050 Acis Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 125000002298 terpene group Chemical group 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开一种蜂胶醇提取物口含片,其含量是重量百分比为25%-35%的蜂胶醇提取物和余量的药学上可接受的含片用载体。本发明的蜂胶醇提取物口含片具有易服用、口感好、吸收快的特点;明显提高了蜂胶中营养成份的吸收利用率,对临床治疗和保健预防又提供了一条服药途径。
Description
技术领域
本发明涉及一种口含片,尤其涉及一种蜂胶醇提取物口含片及其制备方法。
背景技术
蜂胶被医药专家誉为“天然植物药成份宝库”。蜂胶中含有几十类、三百多种天然成分,其中包括三十多种人体必须的微量元素、二十多种氨基酸、数十种芳香化合物、二十多种黄酮类物质,还有丰富的有机酸、萜稀类物质、维生素、酶类、多糖等具有生物学活性的天然成分。
纯蜂胶中主要包括蜂胶黄酮(Propolis Flavonoids)、蜂胶木脂素(PropolisLignin)、蜂胶香豆素(Propolis Coumarins)、蜂胶内脂(Propolis Lactone)、蜂胶蒽醌(Propolis Anthraguinone)、蜂胶芪类(Propolis Stilbene)、蜂胶皂甙(PropolisSaponins)、蜂胶挥发油(Propolis Oils)、蜂胶有机酸(Propolis Organic acis)和蜂胶萜类化合物(Propolis Terpenoides)等十大类近千种有效物质成份。已知蜂胶的药理和药效作用主要有:①抗菌作用。蜂胶具要广谱的抑菌和杀菌作用,并且对抗菌素具有明显的增效作用;②活血化瘀、抗炎镇痛、抗溃疡作用;③抗氧化和抗疲劳作用;④抗病毒、保肝和改善肠胃功能作用;⑤抗流感病毒作用;⑥降血糖作用;⑦软化血管和降血脂作用;⑧降血压作用;⑨免疫增强、延缓衰老、改善微循环和抗癌作用;⑩局部麻醉和促进组织再生作用。鉴于所述蜂胶有如此多的药效作用,人们已对其展开不断深入的研究,其在临床应用和保健食品开发上的前景十分诱人和广阔。但是,经检索,虽有关于蜂胶研究和开发的诸多报道,但未见蜂胶口含片及其制备的报道。
发明内容
针对现有技术的不足,本发明要解决的问题是提供一种蜂胶醇提取物口含片及其制备方法。
本发明所述的蜂胶醇提取物口含片,其特征是,含重量百分比为25%-35%的蜂胶醇提取物和余量的药学上可接受的含片用载体;
其中:所述的蜂胶醇提取物由下述步骤制得:
将蜂胶在-15℃~-25℃条件下冷冻后,粉碎成粗粉,加入其体积量2~4倍的无水乙醇,5℃~20℃浸泡并以10~12转/分的转速搅拌60~84小时,过滤或离心,除去沉渣,滤液浓缩并以0.06~0.07Mpa条件下负压干燥,得粘稠状蜂胶醇提取物。
其中,所述蜂胶醇提取物优选由下述方法制备而成,蜂胶-20℃冷冻后,粉碎成粗粉,加入其体积量2~3倍的无水乙醇,12℃~18℃浸泡并以10转/分的转速搅拌72~75小时,过滤或离心,除去沉渣,滤液浓缩并以0.065Mpa条件下负压干燥,得粘稠状蜂胶醇提取物。
上述蜂胶醇提取物口含片,优选的配伍方式是:含重量百分比为27%-32%的蜂胶醇提取物和余量的药学上可接受的含片用载体。
上述蜂胶醇提取物口含片由如下重量份的组分制成:蜂胶醇提取物55-65份、木糖醇40-52份、蔗糖34-45份、微晶纤维素20-28份、淀粉17-25份、硬脂酸镁5-7份、薄荷醇0.5-1.5份、柠檬酸4.3-6份、香精钠0.2-0.5份。
其中,所述蜂胶醇提取物口含片优选由如下重量份的组分制成:蜂胶醇提取物60份、木糖醇45份、蔗糖40份、微晶纤维素23份、淀粉20份、硬脂酸镁6份、薄荷醇1.0份、柠檬酸4.7份、香精钠0.3份。
本发明所述的重量份可以是μg、mg、g、kg等医药领域公知的质量单位。
本发明涉及的蜂胶醇提取物口含片的剂量以单元剂型中存在的量计算,在单元剂型中本发明涉及的蜂胶醇提取物含量为20-80mg。
成人服用的蜂胶醇提取物口含片量,每日为500-1500mg,分5-8次服用。
本发明提供的蜂胶醇提取物口含片是按照本领域普通技术人员熟知的方法制备的,其基本的制备方式为:
以重量份计,单位为千克,分别称取:蜂胶醇提取物55-65份、木糖醇40-52份、蔗糖34-45份、微晶纤维素20-28份、淀粉17-25份、硬脂酸镁5-7份、薄荷醇0.5-1.5份、柠檬酸4.3-6份、香精钠0.2-0.5份。
将上述蜂胶醇提取物(要求细度达到400目)、木糖醇、蔗糖、微晶纤维素、淀粉混合,用水均匀湿润,把湿润后的混合物过筛并干燥,再过筛,整粒,加入硬脂酸镁、薄荷醇、柠檬酸、香精钠,然后将此混合物压片,每片重200mg-250mg,活性成分蜂胶醇提取物含量为20-60mg。
本发明通过科学调配辅料的成份和含量,使得本发明所述蜂胶醇提取物具有易服用、口感好的特点;由于蜂胶醇提取物细度达到400目,所以本发明中的蜂胶醇提取物在含服的过程中,可以通过口腔粘膜被直接吸收,避免了营养成份通过人体胃肠和肝脏等器官吸收时所产生的损耗,提高了蜂胶醇提取物中营养成份的吸收利用率。因此,本发明的蜂胶醇提取物口含片对临床治疗和保健预防具有重要价值和贡献。
具体实施方式
实施例1:
蜂胶醇提取物口含片:
以重量份计,单位为千克,分别称取:蜂胶醇提取物60份、木糖醇45份、蔗糖40份、微晶纤维素23份、淀粉20份、硬脂酸镁6份、薄荷醇1.0份、柠檬酸4.7份、香精钠0.3份。
将上述蜂胶醇提取物(要求细度达到400目)、木糖醇、蔗糖、微晶纤维素、淀粉混合,用水均匀湿润,把湿润后的混合物过16-22目筛并干燥,再过筛,整粒,加入硬脂酸镁、薄荷醇、柠檬酸、香精钠,然后将此混合物压片,每片重250mg,活性成分蜂胶醇提取物含量为40mg。
实施例2:
蜂胶醇提取物口含片:
以重量份计,单位为千克,分别称取:蜂胶醇提取物55份、木糖醇40份、蔗糖34份、微晶纤维素20份、淀粉17份、硬脂酸镁5份、薄荷醇0.5份、柠檬酸4.3份、香精钠0.2份。
将上述蜂胶醇提取物(要求细度达到400目)、木糖醇、蔗糖、微晶纤维素、淀粉混合,用水均匀湿润,把湿润后的混合物过16-22目筛并干燥,再过筛,整粒,加入硬脂酸镁、薄荷醇、柠檬酸、香精钠,然后将此混合物压片,每片重200mg,活性成分蜂胶醇提取物含量为20mg。
实施例3:
蜂胶醇提取物口含片:
以重量份计,单位为千克,分别称取:蜂胶醇提取物65份、木糖醇52份、蔗糖45份、微晶纤维素28份、淀粉25份、硬脂酸镁7份、薄荷醇1.5份、柠檬酸6份、香精钠0.5份。
将上述蜂胶醇提取物(要求细度达到400目)、木糖醇、蔗糖、微晶纤维素、淀粉混合,用水均匀湿润,把湿润后的混合物过16-22目筛并干燥,再过筛,整粒,加入硬脂酸镁、薄荷醇、柠檬酸、香精钠,然后将此混合物压片,每片重250mg,活性成分蜂胶醇提取物含量为60mg。
实施例4:
蜂胶醇提取物制备:
取蜂胶500g,-20℃冷冻后,粉碎成粗粉,加入无水乙醇1000ml,密封,15℃浸泡并以10转/分的转速搅拌72小时,3500转/分离心去沉淀,滤液回流浓缩,并以0.065Mpa条件下负压干燥,得粘稠状蜂胶醇提取物。
实施例5:
蜂胶醇提取物制备:
取蜂胶,-25℃冷冻后,粉碎成粗粉,加入其体积量3倍的无水乙醇,20℃浸泡并以12转/分的转速搅拌84小时,200目网过滤,除去沉渣,滤液常规浓缩并以0.07Mpa条件下负压干燥,得粘稠状蜂胶醇提取物。
Claims (1)
1.一种蜂胶醇提取物口含片,其特征是,所述蜂胶醇提取物口含片由如下重量份的组分制成:蜂胶醇提取物60份、木糖醇45份、蔗糖40份、微晶纤维素23份、淀粉20份、硬脂酸镁6份、薄荷醇1.0份、柠檬酸4.7份、香精钠0.3份;
其中:上述的蜂胶醇提取物由下述步骤制得:
将蜂胶在-15℃~-25℃条件下冷冻后,粉碎成粗粉,加入其体积量2~4倍的无水乙醇,5℃~20℃浸泡并以10~12转/分的转速搅拌60~84小时,过滤或离心,除去沉渣,滤液浓缩并以0.06~0.07Mpa条件下负压干燥,得粘稠状蜂胶醇提取物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710015492A CN101049320B (zh) | 2007-05-11 | 2007-05-11 | 一种蜂胶醇提取物口含片 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710015492A CN101049320B (zh) | 2007-05-11 | 2007-05-11 | 一种蜂胶醇提取物口含片 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101049320A CN101049320A (zh) | 2007-10-10 |
CN101049320B true CN101049320B (zh) | 2010-05-19 |
Family
ID=38781056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710015492A Expired - Fee Related CN101049320B (zh) | 2007-05-11 | 2007-05-11 | 一种蜂胶醇提取物口含片 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101049320B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101411417B (zh) * | 2008-11-24 | 2012-09-05 | 南京老山药业股份有限公司 | 蜂胶咀嚼片及生产工艺 |
CN102078337A (zh) * | 2011-01-14 | 2011-06-01 | 哈药集团密山蜂业有限公司 | 蜂胶自然还原提取工艺方法 |
CN103494050A (zh) * | 2013-09-26 | 2014-01-08 | 张路扬 | 一种新型蜂胶片产品配方及生产工艺 |
CN108159081A (zh) * | 2017-12-28 | 2018-06-15 | 浙江金童生物科技有限公司 | 一种蜂胶含片及其制备方法 |
CN111407820A (zh) * | 2020-02-28 | 2020-07-14 | 浙江金童生物科技有限公司 | 一种无糖口含片及其制备方法 |
CN111493302A (zh) * | 2020-03-31 | 2020-08-07 | 浙江金童生物科技有限公司 | 一种蜂胶花粉王浆片及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1111949A (zh) * | 1995-03-07 | 1995-11-22 | 徐静兰 | 一种全天然王浆片 |
CN1480202A (zh) * | 2003-06-27 | 2004-03-10 | 中国农业科学院蜜蜂研究所 | 蜂胶滴丸及其制备方法 |
CN1544429A (zh) * | 2003-11-21 | 2004-11-10 | 长春中医学院 | 蜂胶黄酮提取物的制备方法、药物制剂及医药新用途 |
-
2007
- 2007-05-11 CN CN200710015492A patent/CN101049320B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1111949A (zh) * | 1995-03-07 | 1995-11-22 | 徐静兰 | 一种全天然王浆片 |
CN1480202A (zh) * | 2003-06-27 | 2004-03-10 | 中国农业科学院蜜蜂研究所 | 蜂胶滴丸及其制备方法 |
CN1544429A (zh) * | 2003-11-21 | 2004-11-10 | 长春中医学院 | 蜂胶黄酮提取物的制备方法、药物制剂及医药新用途 |
Non-Patent Citations (2)
Title |
---|
. |
说明书第2页第2行至9页第13行. |
Also Published As
Publication number | Publication date |
---|---|
CN101049320A (zh) | 2007-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101049320B (zh) | 一种蜂胶醇提取物口含片 | |
CN102872306B (zh) | 治疗心脑血管疾病的复方富硒中药组合物及其制备方法 | |
CN102225138B (zh) | 一种用于治疗骨折的中药组合物及其制备方法和应用 | |
JP2003192605A (ja) | リパーゼ阻害剤 | |
CN110141638A (zh) | 一种用于调理痛风的中药组合物和应用 | |
CN103566150B (zh) | 一种具有降血脂作用的药食同源食品的组合物及其应用 | |
CN104068177A (zh) | 天然植物保健益寿茶 | |
CN101537160B (zh) | 一种排毒养颜保健品 | |
Upadhyay | Bel plant: A source of pharmaceuticals and ethno medicines | |
CN102824626A (zh) | 一种治疗过敏性鼻炎的药合泡剂及其制备方法 | |
KR101988102B1 (ko) | 백삼 및 짚신나물, 단삼, 미역취 복합 추출물을 유효성분으로 함유하는 항산화 조성물 | |
CN101700260A (zh) | 马齿苋子多糖颗粒制剂及其制备方法 | |
CN105285288A (zh) | 一种辅助治疗咽喉炎的奶糖及其制备方法 | |
JP2004352626A (ja) | 植物由来成分を含有する抗コレステロール剤 | |
CN103610931B (zh) | 一种治疗结核性胸膜炎的中药 | |
KR20000037815A (ko) | 생약재를 함유한 건강식품 | |
CN105663439A (zh) | 一种用于预防和治疗糖尿病的药物组合物及其制备方法 | |
KR20030079289A (ko) | 숙취해소용 탄산음료 제조방법 및 그 조성물. | |
CN110638908B (zh) | 一种用于治疗缺血性脑卒中的中药组合物及其制备方法 | |
CN111419952B (zh) | 一种具有止血止痛作用的中药组合物及其制备方法和应用 | |
Deore et al. | UDUMBARA (FIGARO RACEMOSA): A PHARMACOGNOSTIC | |
CN106108009A (zh) | 小蓟提取液、含有小蓟活性成分的保健品及其制备方法 | |
CN104922549A (zh) | 一种治疗小儿蛔虫症的中药制剂及制法 | |
CN105012642A (zh) | 一种活血化瘀,止血止痛的中药组合物的制备方法 | |
Simons | The Healing Power of Plants: Medical Plants from Abuta and Acerola to Yohimbe and Yucca: a Practical Selection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20130511 |